Paulette Andreotta is a strategic and results-driven Scientific Director specializing in preclinical development, particularly in respiratory, immunology, pharmacology, and ADME/DMPK. Currently serving as the Executive Director of Pharmacology at MannKind Corporation, Paulette has a proven track record of advancing biotherapeutic programs from discovery through IND/CTA submission and early clinical development. Previous roles include leadership positions at Moderna and Pulmatrix, where they spearheaded significant therapeutic advancements in inhaled mRNA-LNP technologies. Paulette holds a Master of Science and is pursuing a PhD in Pharmacology at Yale School of Medicine, further underscoring their commitment to impactful therapy development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices